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ABSTRACT
Objective: To evaluate and inform emergency supply
of prescription-only medicines by community
pharmacists (CPs), including how the service could
form an integral component of established healthcare
provision to maximise adherence.
Design: Mixed methods. 4 phases: prospective audit
of emergency supply requests for prescribed medicines
(October–November 2012 and April 2013); interviews
with CPs (February–April 2013); follow-up interviews
with patients (April–May 2013); interactive feedback
sessions with general practice teams (October–
November 2013).
Setting: 22 community pharmacies and 6 general
practices in Northwest England.
Participants: 27 CPs with experience of dealing with
requests for emergency supplies; 25 patients who
received an emergency supply of a prescribed
medicine; 58 staff at 6 general practices.
Results: Clinical audit in 22 pharmacies over two
4-week periods reported that 526 medicines were
requested by 450 patients. Requests peaked over a
bank holiday and around weekends. A significant
number of supplies were made during practice opening
hours. Most requests were for older patients and for
medicines used in long-term conditions. Difficulty in
renewing repeat medication (forgetting to order, or
prescription delays) was the major reason for requests.
The majority of medicines were ‘loaned’ in advance of
a National Health Service (NHS) prescription.
Interviews with CPs and patients indicated that
continuous supply had a positive impact on medicines
adherence, removing the need to access urgent care.
General practice staff were surprised and concerned by
the extent of emergency supply episodes.
Conclusions: CPs regularly provide emergency
supplies to patients who run out of their repeat
medication, including during practice opening hours.
This may aid adherence. There is currently no feedback
loop, however, to general practice. Patient care and
interprofessional communication may be better served
by the introduction of a formally structured and funded
NHS emergency supply service from community
pharmacies, with ongoing optimisation of repeat
prescribing.
INTRODUCTION
The Medicines Act 1968, and latterly the
Human Medicines Regulations 2012, permit
community pharmacists (CPs) to supply
prescription-only medicines (POMs) without
a prescription in an emergency when
requested by either a prescriber or the
patient.1 This enables pharmacists to use
their professional judgement to ensure con-
tinuous supply of medicines. Pharmacists
‘must be satisﬁed’ that there is an ‘immediate
need’ for the medicine, while also consider-
ing the patient’s well-being and any conse-
quences of not supplying (box 1).2 In this
paper, the term ‘emergency supply’ refers to
both the supply of medicines where a charge
is made directly to the patient, and to the
‘loan’ of medication made by CPs where no
Strengths and limitations of this study
▪ This paper expands the sparse literature about
the occurrence and characteristics of emergency
supplies of prescription-only medicines made
through community pharmacies to patients.
▪ This paper examines the perspectives of the
three major stakeholder groups—patients, phar-
macists and general practice staff.
▪ The participants were self-selected and this may
introduce bias.
▪ The number of participants in each stakeholder
group was modest.
▪ The study has generated useful underpinning
information for further practice and policy devel-
opment in this field.
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charge is made to the patient and the supply is subse-
quently reconciled against a future National Health
Service (NHS) prescription. Emergency supplies may
also be made at the request of a prescriber, but those
are not included in this paper. For loans in anticipation
of a future NHS prescription, the additional work (ie,
clinical check, determining evidence of previous supply,
dispensing and documentation) undertaken by the
pharmacists is not remunerated, either by the patient or
the NHS. For an emergency supply where a future NHS
prescription is unlikely to be obtained, usually for
outside visitors to the locality, a charge is made to the
patient to cover the medicine costs, and a discretionary
small amount for administration.
Dispensing services around the world are likely to iden-
tify with the issues of emergency supply or owing/loaning
medication outlined above. Where prescription medicine
supply is tightly regulated—like in the UK, the USA,
Europe, Canada and Australasia—an emergency supply
service similar to the England version prevails. In coun-
tries where more prescription medicines are sold in phar-
macies, like the Middle and Far East, patients are able to
purchase these medicines directly, although evidence of
previous use (such as old medicine packets) may be
required. There are also some countries where no provi-
sion for pharmacy emergency supply exists and where the
patient would have to visit a doctor for a prescription.
A 1998 survey of CPs by O’Neill et al3 demonstrated
that requests for emergency supplies and medicine loans
were being made on a frequent basis: at least monthly
for three-quarters of respondents, at least weekly for
half, and at least daily for 1 in 10. Respondents per-
ceived emergency supplies as an important service, but
over three-quarters felt it was open to misuse. Other
studies in this ﬁeld suggest variability in professional
decision-making processes and justiﬁcations, and there
remains no clear deﬁnition as to what constitutes ‘imme-
diate need’.4–8 While pharmacists identify themselves as
acting in the patient’s best interests, previous studies
have not explored what impact supply or refusal might
have on patient adherence to treatment. A signiﬁcant
number of emergency medicine requests are being
made to urgent care services. Urgent Care 24 (UC24), a
local provider of general practitioner (GP) out-of-hours
services in Liverpool, reported that a total of 5156
repeat medication requests out-of-hours were received
by the service in the period of September 2012–
September 2013,9 for a patient population of approxi-
mately 750 000.
NHS England’s Call to Action highlighted challenges
regarding more patients with long-term conditions and
increasing patient expectations.10 CPs are named among
healthcare professionals who can support patients in
managing long-term conditions in primary care. A Royal
Pharmaceutical Society (RPS) report on future models
of care for pharmacy11 highlights the potential of com-
munity pharmacy in GP out-of-hours services and urgent
care. Joint work between NHS England and the
Pharmaceutical Services Negotiating Committee has
explored extending pharmacy services to relieve pres-
sure on accident and emergency (A&E) departments
while maintaining standards of care, including amend-
ments which permit NHS England Area Teams (regional
commissioners) to commission ‘Emergency Supply at
NHS expense’ as an Enhanced Service from community
pharmacies.12–14 A review of the literature has identiﬁed
only a few studies that have explored emergency supplies
by community pharmacies in depth; the majority were
based in the UK.3–8 Moreover, there is a need for a holis-
tic examination, incorporating multiple viewpoints, of
how the emergency supply service at community phar-
macies may best ﬁt within current and established
health and social care provision in order to best support
patient care. This evaluation aims to describe the
current proﬁle of emergency supply activity in commu-
nity pharmacies to explore and inform future practice.
Box 1 Emergency supply at the request of a patient
Interview: the pharmacist must interview the patient, preferably face to face
Immediate need: the pharmacist must be satisfied that there is an immediate need for the prescription-only medicine (POM) and that it is
not practical for the patient to obtain a prescription without undue delay
Previous treatment: the POM requested must previously have been used as a treatment and prescribed by a relevant prescriber
Dose: the pharmacist must be satisfied of knowing the dose that the patient needs to take
Not for controlled drugs, except phenobarbital: medicinal products cannot be supplied if they consist of or contain any schedule 1, 2 or 3
controlled drugs; phenobarbital can be supplied to patients of UK-registered prescribers for the purpose of treating epilepsy
Length of treatment: if the emergency supply is for a controlled drug (ie, phenobarbital or schedule 4 or 5 controlled drug), the maximum
quantity that can be supplied is for 5 days’ treatment. For any other POM, no more than 30 days can be supplied except:
▸ If the POM is insulin, an ointment, a cream or an inhaler for asthma (ie, the packs cannot be broken), the smallest pack available in the
pharmacy should be supplied;
▸ If the POM is an oral contraceptive, a full treatment cycle should be supplied;
▸ If the POM is an antibiotic in liquid form for oral administration, the smallest quantity that will provide a full course of treatment should
be supplied.
Records kept: an entry must be made in the POM register on the day of the supply (or, if impractical, on the following day). The entry needs
to include: date supplied; name (including strength and form where appropriate) and quantity of medicine supplied; name and address of
patient; and information on nature of emergency
Labelling: in addition to standard labelling requirements, the words ‘Emergency Supply’ need to be added to the dispensing label
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METHODS
This study used a mixed methods approach over four con-
secutive phases. Data collection was undertaken by practis-
ing CPs in North West England alongside the research
team. Participants in all phases gave informed consent
before taking part. An overview of the multiphased study is
provided in table 1 (Research Protocol v1).
Phase 1: Clinical audit data of emergency supplies in partici-
pating pharmacies across North West England, over two 4-week
collection periods. Pharmacies were purposively sampled
via a recruitment pack, containing study information
and consent forms, posted to them by the local Primary
Care Research Network and Liverpool John Moores
University (LJMU). Through this process, diversity in
pharmacy ownership (independent vs corporate),
setting and opening hours—and pharmacist gender and
practice experience—was maximised. CPs in the partici-
pating pharmacies were asked to document the
characteristics of all emergency supplies of prescribed
medicines over two 4-week periods (October/November
2012 and April 2013). A pad of preprinted paper audit
forms was supplied to each pharmacy. The form was
created, piloted and validated by the practising CPs on
the research team (GBP and NM) (phase 1—data
capture form—1 October 2012.pdf (v1.0)—see online
supplementary ﬁle). Details captured for each episode
included: the day/date of the request; patient age and
postcode; the quantity, name, dosage form and dose
given of the medicine; the reason for the request, and
whether the supply was made. No identiﬁable informa-
tion was recorded on those forms.
Phase 2: Semistructured telephone interviews with CPs
working at pharmacies across North West England. A sub-
group of specially trained CPs who volunteered from the
phase 1 audit cohort interviewed the other pharmacists,
who were based in pharmacies with diverse locations,
settings, opening hours and ownership type. Pharmacies
who had participated in the phase 1 audit were invited
to take part, and other pharmacists were recruited via
local professional networks. Recruitment packs contain-
ing information and consent forms were provided to
potential participants (phase 2—participant information
sheet—1 Oct 2012.pdf (v1.0)—see online supplemen-
tary ﬁle). Those who returned a completed consent
form were interviewed. These telephone interviews
(undertaken February/April 2013) explored pharma-
cists’ experiences and opinions in relation to requests
for emergency supplies and loans (phase 2—interview
schedule—1 Oct 2012.pdf (v1.0)—see online supple-
mentary ﬁle). It also explored their reﬂections on chal-
lenges encountered and their resolution strategies.
Peer-to-peer interviewing facilitated effective probing of
responses to elicit details of difﬁcult situations through
shared professional insight into the dilemmas described.
This technique has been utilised previously during inter-
views conducted by GPs with fellow practitioners;15 these
respondents recognised the interviewer as a fellow clin-
ician, resulting in broader and more personal accounts
of their attitudes and behaviour in clinical practice.
Interviews were audio recorded with consent from
interviewees.
Phase 3: Telephone interviews undertaken by the research
assistant (ECS) with patients who received emergency supplies/
loans of POMs. Over 6 weeks in April/May 2013, patients
requesting emergency supplies or loans of POMs at par-
ticipating pharmacies were invited to participate in a
follow-up telephone interview after using the service. At
the end of the supply, they were given a recruitment
pack by the pharmacist and replied direct to the
research assistant (RA) (phase 3—participant informa-
tion sheet—28 November 2012.pdf (v3.0)—see online
supplementary ﬁle). No demographic data were col-
lected. These semistructured telephone interviews
explored patients’ views, experiences and prior knowl-
edge of the service, as well as the perceived impact of
the emergency supply on the continuity of their
medicines’ supply and adherence (phase 3—interview
schedule—1 Oct 2012.pdf (v1.0)—see online supple-
mentary ﬁle). Interviews were completed within 2 weeks
of the initial request and were audiorecorded with
patient consent and transcribed verbatim.
Phase 4: Qualitative interactive feedback sessions with
medical practice teams. A subgroup of CPs volunteered
from the phase 1 cohort to do this work and received
further training from the research team and, with
support from the RA, presented interim ﬁndings from
phases 1–3 to their local general practice team. Sessions
took place in October/November 2013, and explored
practice staff’s views and experiences regarding the
emergency supply service and its impact on, and rele-
vance to, their workﬂow and patient well-being (phase 4
—practice staff feedback session discussion schedule.pdf
(v1.0)—see online supplementary ﬁle). Practice staff
provided written informed consent to take part in the
Table 1 Overview of study phases
Project phases
Phase 1:
Clinical audit of emergency supplies in participating
pharmacies over two 4-week collection periods
October–November 2012 and April 2013
Phase 2:
Semistructured telephone interviews with pharmacists
working at pharmacies across North West England
February–April 2013
Phase 3:
Follow-up telephone interviews with service users who
received emergency supplies/loans of prescription-only
medicines
April–May 2013
Phase 4:
Qualitative interactive feedback sessions with medical
practice teams
October–November 2013
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session (phase 4—participant information sheet—1 Oct
2012.pdf (v1.0)—see online supplementary ﬁle). To
protect patient anonymity, CPs began sessions by
explaining that the ﬁndings were from multiple study
sites across North West England and incorporated many
patients who were not registered at that practice. Field
notes were taken during the discussions by the RA and
consent to participate was obtained from all attendees.
Data analysis
Data were entered from the forms into IBM SPSS V.21
statistical software, where it was subjected to basic descrip-
tive analysis. Qualitative data from all other phases were
transcribed verbatim and thematically analysed for emer-
gent themes, using NVivo V.10 software (QSR
International). A ‘directed content analysis’ approach
was used.16 Primary attention was directed at identifying
broad categories of data, followed by speciﬁc line-by-line
categorisation. The study objectives provided a clear
source of categories with which to organise participants’
responses, while allowing other themes to emerge.
Analysis examined commonalities between participants
as well as contrasting perceptions of the emergency
supply process. Members of the project team, and the
CPs who conducted the interviews, further reviewed
emergent themes to ensure robustness regarding coding
and reconstruction.
Data from all phases were then triangulated to provide
an understanding of the service from multiple perspec-
tives, enhancing the validity and reliability of the study
outcomes.
RESULTS
Participants in each phase of the project
Phase 1 audit: Twenty-two pharmacies took part in the
phase 1 audit (table 2). Diversity in pharmacist experi-
ence, gender and length of time since registration was
seen. Sites were most frequently located in small parades
of neighbourhood shops (9/22) or within or adjacent to
the health centre (8/22) (table 2). Fourteen pharmacies
(63.6%) were closed at weekends, and three (13.6%)
opened for 100 h over 7 days.
Phase 2 CP interviews: Following training in telephone
interview techniques by the research team, ﬁve pharma-
cist researchers (PRs) completed recorded semistruc-
tured peer telephone interviews with 26 CPs working at
pharmacies across North West England. Interviewees
were based in pharmacies with diverse locations, settings,
opening hours and ownership type, that is, independent,
small/medium chain and nationwide multiple. Nineteen
of the pharmacists interviewed had been involved in
phase 1 of the study with the remainder being directly
recruited by the PRs via professional networks.
Interviews lasted between 7 and 36 min (mean 14 min).
Phase 3 patient interviews: From the 191 recruitment
packs distributed by 22 pharmacies, 30 responses were
received from patients at 9 pharmacies (16% response
rate). Semistructured interviews were completed with 25
patients (2 declined to take part when contacted and 3
could not be contacted). Interviews lasted between 3
and 9 min (mean 5 min).
Phase 4 general practice feedback sessions: Fourteen
general practice teams were invited to take part in this
phase, of which six agreed. Reasons given for non-
participation included: introduction of Electronic
Prescription Service (EPS) occupying staff time; and a
policy of refusing meetings with external parties. In
some cases, practice teams appeared comfortable with
meeting to hear the study ﬁndings, but were reticent
about their opinions being captured. The length of time
made available for the meeting varied between practices;
some added the discussion to their monthly staff
meeting agenda and others arranged a separate, full-
length discussion. Different general practice staff cat-
egories were represented at the feedback sessions, which
took place in October/November 2013. They included 5
practice managers; 25 GPs; 12 practice nurses; 10
Table 2 Characteristics of participating pharmacies
Characteristic Number of pharmacies
Percentage of
total pharmacies (n=22)
Type of pharmacy ownership
Single independent pharmacy 4 18.2
Small group of 2–5 pharmacies 3 13.6
Local group of more than 5 pharmacies 11 50.0
National group of over 100 pharmacies 4 18.2
Location of pharmacy
Local parade of shops 9 40.5
Health centre 8 36.4
Town centre/high street 3 13.6
Other 2 9.5
Standard days open
Monday–Friday 14 63.6
Monday–Saturday 5 22.8
Monday–Sunday 3 13.6
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reception and administration staff; 2 healthcare assis-
tants; 2 district nurses; 1 phlebotomist; and 1 health
visitor. Attendance ranged from 2 (the lead GP partner
and practice manager) at one surgery to 17 team
members at another. The duration of the six sessions
ranged from 18 to 62 min (mean 36 min).
The results of the study are presented in an integrated
approach by theme, across methods.
Frequency and characteristics of emergency supplies
Emergency supply requests were made for a total of 526
medicine items by 450 patients at 22 community phar-
macies over the two 4-week audit collection periods.
Most requests were for single items (405/450 occasions;
90%) with three or more items requested on 17 occa-
sions (4%).
A higher proportion of requests were recorded on
either side of the weekend (Mondays and Fridays) than
on other days, with around a quarter of items requested
(123/526; 23%) on a Friday (ﬁgure 1). In the eight
pharmacies open during weekends (3 open both days; 2
all day Saturday; and 3 Saturday morning only), emer-
gency supply requests were made for 65 items during
this period, reﬂecting a higher rate per pharmacy in
comparison to any of the weekdays.
Almost two-thirds (16/26) of CPs interviewed in phase
2 reported normally receiving requests at least daily, with
four describing multiple requests per day, although
requests rates were often variable. At phase 4 feedback
sessions, some participants, including GPs and practice
managers, were surprised to ﬁnd that requests were
received across the week; they regarded emergency sup-
plies as something that should only happen outside
practice opening times.
Emergency supply requests in phase 1 occurred for
patients aged from 3 months to 92 years, with 13 (3%)
for children under the age of 12 years. Although there
was a trend towards more requests from older patients, a
substantial number were made by young and middle-
aged adults (ﬁgure 2).
Over two-thirds (18/26) of CP interviewees in phase 2
highlighted older people as the client group most fre-
quently requesting emergency supplies. Some respon-
dents (6/26) felt that this group had more difﬁculties in
ordering their repeat prescriptions than younger
people, but others (3/26) felt that this was simply
related to the more frequent use of medicines in this
group. Younger and middle-age groups were thought by
three interviewees to be likely to request emergency sup-
plies due to other commitments, such as working or
caring for others.
Most requests in phase 1 were for medicines used in
long-term conditions and the therapeutic areas broadly
mirrored national prescribing proﬁles.17 The most com-
monly requested medicines were used for cardiovascular
(32%, 169/526), respiratory (13%, 70/526), endocrine
(12%, 63/452) and gastrointestinal conditions (11%,
56/526). Speciﬁc medicines that might lead to a risk of
adverse clinical implications if a supply was not provided
included treatment for a renal transplant (azathioprine)
and cancer (letrozole). The wide range of medicines
involved was conﬁrmed by CPs in phase 2, with most
stating that the majority of requests were for medicines
for long-term conditions.
Reasons for requests
Difﬁculties associated with renewing repeat medication
were the major reason recorded in phase 1 audit for
emergency requests, including patients having ‘forgotten
to order’ (364/526; 69%), delays with prescriptions
being issued (16/526; 3%); ordered items missed off
prescriptions (14/526; 3%); and errors in ordering
repeat supplies via the pharmacy, for example, incorrect
strength (8/526; 2%). Patient interviewees in phase 3
also reported repeat medication ordering as a cause for
their emergency supply request, particularly at the end
Figure 1 Distribution of
emergency supply requests: days
of the week (n=526) (POM,
prescription-only medicine).
Figure 2 Distribution of emergency supply requests by
patient age category (n=449; missing=1).
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of a week where a supply was needed to cover the
weekend. Some patients admitted that this was often an
oversight on their part, but others mentioned life cir-
cumstances contributing to their problems with the
ordering systems, including a 24 h carer and those who
worked full-time. Other reasons for requests recorded in
phase 1 were: insufﬁcient quantities prescribed (24/526;
5%); requests following increases in the prescribed dose
leading to shortages (7/526; 1%); and prescribed quan-
tities of medicines being out-of-sync with multiple repeat
dates (30/526; 6%). Problems with unsynchronised med-
icines prescribing, that is, where one or more additional
medicines are started at a different time to other medi-
cines, were also reported as the cause of the problem
for ﬁve of the phase 3 patients.
Responding to requests
The majority (489/526; 93%) of item requests in phase
1 related to medicines ‘loaned’ to the patient in antici-
pation of an NHS prescription. In the few cases (17/
526; 3%) where a charge was made, this was usually
because the patient was on holiday and had forgotten
their medicines and it would not have been practical to
obtain a prescription. In all of the emergency supplies
made to the 25 phase 3 patients, medicines had been
supplied as a loan, with a subsequent NHS prescription
being requested by the pharmacist to claim payment.
When prompted about payment, phase 3 patients were
largely unaware that the service was not a standard aspect
of the NHS supply service and, in many cases, felt that
they should not have to pay as they were exempt from
prescription charges. In the phase 4 feedback sessions,
practice staff also considered loans the more appropriate
mechanism (rather than charging the patient), since the
majority of requests related to repeat medication from
the patient’s regular pharmacy. However, one GP com-
mented that charging patients may act as a deterrent to
the patient making a future emergency supply request,
suggesting that some individuals may use the loan mech-
anism in preference to the standard procedure.
Impact on medicines adherence
Over half of the phase 2 CPs (15/26) described the
emergency supply of medicines as a mechanism to
ensure continuity of treatment as having a positive inﬂu-
ence on adherence. Additionally, seven described it as a
‘safety net’ and a further two described its importance
where there were delays in the processing of a prescrip-
tion. Respondents also speculated that, without emer-
gency supplies being available, some patients would
simply stop their treatment until the medicines were
available again.
Four of the phase 2 CPs considered the emergency
supply service to have little or no impact on patient adher-
ence. Nine expressed frustration that, although they saw
the beneﬁts in genuine emergencies, some patients
abused the system, rather than managing their medicines
properly. However, emergency supply requests were
considered to provide opportunities to engage such
patients over adherence and managing their medicines via
informal discussion or through Medicines Use Reviews, an
NHS-funded service for pharmacists to discuss broad
issues of medicine-taking with their patients.18
Some phase 2 CPs and phase 4 GPs agreed that, while
certain medicines did not need to be supplied urgently,
if emergency supplies were refused in such cases, this
might give patients mixed messages about the import-
ance of adherence (box 2). In addition, some GPs high-
lighted that failure to supply could be interpreted as
negligence if a patient were to experience an adverse
health event owing to the interruption in treatment.
Phase 3 patients were asked to reﬂect on the impact of
this emergency supply on the management of their med-
icines and condition. Many respondents explained that
the supply had maintained their use of medicines as pre-
scribed and one-third (8/25) said that this gave them
peace of mind with respect to their treatment.
Two-thirds of patients (16/25) emphasised the import-
ance of an uninterrupted supply of medicines, describ-
ing the possible impact that they believed a missed dose
might have (box 3). Patients also recognised that emer-
gency supplies should not be a routine mechanism for
them to obtain medicines, and one respondent
described how the incident had made her more vigilant
about ordering medication on time to ensure that she
had a continuing supply.
Phase 3 patients described possible alternative actions
that they would have taken in the absence of an emer-
gency supply. Half (12/25) said they would speak to
their GP or the surgery receptionist in the ﬁrst instance,
although some were unsure whether an appointment
would be possible at short notice. Using the walk-in
centre, the A&E department or GP out-of-hours service
was also mentioned by four respondents.
Around a quarter of phase 3 patients (7/25) said that
they would have just done without their medicines until
their prescription was ready. In some cases, participants
felt that, although this would not be ideal, it would not
cause any particular harm. However, others commented
that this might have a negative impact on them. Four
respondents described purchasing over-the-counter
medicines as a possibility, although they felt that these
would be less effective than their usual medication. One
service user reported having previously borrowed medi-
cines from friends (warfarin) when he ran out. Practice
staff were not surprised by the alternative actions that
patients described in the phase 3 interviews, including
even this case of the individual who borrowed warfarin
from his friend, as they recognised such behaviour from
their own patients.
Changes to practice
Phase 2 CPs highlighted that the numbers of loans cur-
rently supplied were a small, but important, facet of the
existing NHS supply arrangements and structuring these
supplies as a funded NHS service would be helpful
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(box 4). It was suggested that this could operate as an
advanced service (nationally commissioned), such as
Medicines Use Reviews, or an enhanced service (locally
commissioned), such as the minor ailments service in
operation in the study area. Respondents felt that such a
service would need clear and transparent terms of
service and associated fees to provide recognition of the
additional workload for the CP and the expertise
involved in providing the service. A national service spe-
ciﬁcation was also considered important to ensure a con-
sistent service, which would be useful for patients and
other health professionals in understanding and refer-
ring to the service.
The importance of patients accessing care in the right
place (GP/out-of-hours service/A&E/Community phar-
macy, etc.) for their needs was also emphasised.
Pharmacists and GPs identiﬁed the role that CPs could
have in removing unnecessary demand from GP
out-of-hours services regarding medicines supply and
that this could be a driver for change to a funded emer-
gency supply service in community pharmacies. This
provision was considered to be likely to be comparatively
cost-effective, directing limited NHS resources to be used
in the best way. A coordinated approach to promoting
such a service was preferred, with other relevant NHS
service providers having clear pathways for referral. One
GP contextualised the emergency supply issue as part of
the broader challenge of supplying long-term repeat pre-
scriptions, and felt that the pharmacist might take a
greater facilitating role that would reduce the need for
practice staff administration. In contrast, another GP felt
that emergency supplies were being requested by only a
small proportion of the patient population and ques-
tioned whether the resource could be justiﬁed.
Although it was recognised that there would always be
a cohort of patients who would request this type of
supply, it was strongly felt that a formal service should
not support patients who repeatedly forgot to order
repeat prescriptions and may be considered to be
abusing the system. Continued patient education at each
point of access to the service, together with appropriate
action by pharmacists/GPs (eg, synchronisation of
Box 2 Phase 4 practice staff quotes
The challenges of emergency supply
I think the number of steps involved it sounds easy from the outside. The patient gives in the script and he expects it to happen like
that, but there are so many steps involved in it coming to the doctor and going to the pharmacist…They come at three o’clock and
they want a script by five o’clock before you close. So I need to drop everything what I’m doing to do the script so it puts a lot of
pressure on the service. You just need two or three people to unbalance the whole thing. (Pract1, GP)
I know from experience on a Friday everybody needs that medication because they can’t wait the two days till Monday…we know
what it’s like but it’s hard for us to know what is urgent and, you know, what can wait till Monday. (Pract3, Receptionist)
Promoting adherence
Even though we know realistically somebody’s blood pressure isn’t going to shoot up and somebody’s not going to suddenly have a
stroke, psychologically trying to convince patients of that is very difficult…and if something adverse did happen, they would blame
the fact that they didn’t have the medication. It’s, it’s hard to get the balance right…‘You can miss it every now and then. It doesn’t
matter’. Yes you’re sending a contradictory message…If you start saying, ‘Well that doesn’t matter that much’, people will stop taking
medication regularly or might stop it altogether. (Pract5, GP)
It’s not ideal but…you can’t leave the patient without any medication and that’s the decision you’ve got to make…you’re put in a diffi-
cult position but[you have to do] what’s in the patient’s best interests, I suppose. (Pract2, GP)
Communication and relationships
I’ve worked in practices where there’s very often been a pharmacist like you who you get to know personally…The problem is when
requests are coming for prescriptions to pay back tablets that have been lent out from a chemist that you’re not really that familiar
with, and we start to wonder about what the patient’s up to. (Pract5, GP)
The thing is I think the problem is because they[patients] can, they can actually access you and bypass us. The whole problem stems
from that. If you say everything has to come through the GP and they have to come here for the repeat prescriptions that problem
doesn’t arise…So those incidents should not happen. (Pract1, GP)
Changes to practice
We do get reports from Out-of-Hours services that people present at Out-of-Hours services requesting prescriptions for inhalers or
blood pressure or heart medications etc. and clearly that’s using out-of-hours resources which isn’t appropriate. So if the pharmacist
is able to do that, then it’s going to save pressure on the Out-of-Hours services. (Pract6, GP)
There’s a few[patients] who would misuse it so we need to identify those…I think it[feedback to GP] gives you a bit more confidence
doesn’t it? As a pharmacist: ‘I’ve done this, I’ve let the GP know’ and there’s a safety net somewhere that would pick up a problem if
there was an issue. I think that’s not a bad idea. (Pract1, GP)
If we were informed who was using the service we could explore what were the reasons and maybe reduce that.’ (Pract3, practice
nurse)
I for the life of me don’t understand why we have to spend so many hours a week writing prescriptions for things that people know
that they should be on all the time. And I’ve got no understanding as to why we don’t do that through pharmacies.[…] I think phar-
macies would be far better at actually monitoring the number of prescriptions that have gone through. (Pract5, GP)
Ninety-nine percent of patients are taking charge or responsibility for their prescriptions; we are going after that one percent. Are we
going to throw so many resources at this one per cent? (Pract1, GP)
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medications, review of asthma inhaler use, etc), was con-
sidered to be preferable and, over time, likely to lead to
fewer patients making repeated requests. Formalised
feedback to the GP about the emergency supply made
might also help to improve appropriate use of the
service and was supported by CP, GP and nurse
participants.
DISCUSSION
Results indicate that CPs are supporting continuity of
medicines use by supplying them to patients without
prescription on an occasional, but routine, basis. This is
particularly prevalent around times when other health
services are not available, such as weekends and bank
holidays, but also happens ‘in-hours’ during the week.
Many requests are from elderly patients and individuals
with long-term conditions, but all age groups are repre-
sented and a wide range of medications involved.
Practice staff seemed unaware of the extent of emer-
gency supply, especially during the week when practices
were open. Practice staff acknowledged, however, that
patients made requests for medication that they needed
more quickly than the standard 48 h wait. GPs and
reception staff experienced pressure and disruption
from such requests. While the systems in place for man-
aging repeat medication seemed to work well for the
majority of patients, there were issues faced by a signiﬁ-
cant minority, which were related to multiple factors.
These included: practice opening hours; forgetfulness;
process errors; and competing priorities. If patients had
not accessed the emergency supply service, many would
have stopped taking their medication or accessed urgent
care services, which was considered inappropriate by
pharmacists and practice staff. Practice staff and GPs
recognised the potential for mixed messages about
adherence to have an impact on future medicine-taking.
The methodology used in this study brought a
number of beneﬁts and inevitable limitations. The multi-
phased, mixed methods nature of this study involved col-
lation of data from multiple perspectives and provided a
holistic view of the provision of emergency supplies of
POMs through community pharmacies. Sufﬁcient data
were collected in all qualitative phases to reach theoret-
ical saturation. Peer-to-peer interviewing has been shown
to enable interviewees to be more open about issues
encountered in practice, with interviewers better placed
to probe answers using their professional experience.15
Any inconsistencies across interviewers were minimised
by group training and a review of transcripts by the RA
Box 3 Phase 3 patient quotes
Importance of uninterrupted supply
She has to take it every day…she has brittle asthma and
she’s been in the paediatric ICU on occasion. She had been
poorly and she absolutely does need it. It’s vital for her.
(Mother who requested emergency supply of an inhaler for
her daughter aged 11)
This resident is dependent on this medication on a daily
basis. It’s to do with her mental health issue. It was import-
ant that we made sure that she took her medication other-
wise there would be relapses. (Member of staff at
supported living home for people with learning disabilities
who requested emergency supply of medicines prescribed
for a tenant’s mental health condition)
It was on a loan because obviously I was picking my full
prescription up the next day so it was just to tide me over
for that one day. (Female who experienced delay in repeat
prescription being forthcoming due to staff shortage at the
GP’s surgery)
Use of urgent care services
I probably would have had to have gone Out-of-Hours or
maybe up to A&E or drop in centre—probably explain my
situation from that point of view…So yeah, it would have
been far more complicated and far more awkward to be
able to resolve the situation, the predicament that I was in.
(Male, requested emergency supply as he had left regular
medication at holiday home after weekend visit)
Well I probably would have demanded to see the doctor
and then if not, I would have called the Out-of-Hours prob-
ably if I was in a mood…Depends what type of mood I’m
in but I really was needing them because if I haven’t had
them for a few days I start getting really bad. (Female,
requested emergency supply of medication to control
symptoms of anxiety)
Box 4 Phase 2 community pharmacist quotes
Communication and relationships
I’ve had a dilemma fairly recently on someone wanting an
emergency supply…she was taking something differently
from what was recorded on the computer…It was lucky the
surgery was open so I could get in touch…She was taking
sertraline[anti-depressant medication] and she was taking
two times 100 milligrams where in fact it had been
reduced. She did initially take that, but it had been
reduced…she got a bit confused. (P3)
I had a guy the other day who was overusing his Airomir
(salbutamol) inhaler. He was going through one every two
weeks and I was saying, “You shouldn’t be using that
much” because I can tell by looking at him he’s not that ill
in a sense, you know, he’s in his fifties but he wasn’t col-
lapsing on the floor with breathing difficulties or anything.
So I ended up phoning the doctors and they actually got
him in to see the nurse. (P1)
Changes to practice
Well I think it should become part [of ] the pharmacy con-
tract. An emergency supply really is no different from Care
of the Chemist, the minor ailments scheme. So the minor
ailments scheme attracts a fee and a consultation fee so
why could we not have something similar for the emer-
gency supply scenario? (CP20)
It would be nice if we could package up some sort of
service across particular boundaries or groups so we
[pharmacists and practice staff ] all work together and we
don’t have the confusion for the patient really.[…] Yes
more structure and a more robust system that we could all
adhere to, which would be patient friendly. (CP7)
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and individual interviewer. The experiences of the
group of CPs who were involved as researchers in this
multiphased study are published in a separate paper.19
This paper provides more detail about the methodo-
logical training and data collection techniques provided
to the group. CPs’ existing rapport with their local
general practice team also enhanced the feedback ses-
sions in phase 4, with open dialogue giving greater
understanding of the practice team perspective.
However, data were not routinely collected in phase 1
regarding requests for supplies that were refused, and it
is not known how many patients were referred to other
services to obtain medicines. Moreover, no patient inter-
views undertaken in phase 3 of the study involved
requests for emergency supply of POMs that had been
refused. Additionally, the time of request was not
recorded, so it is not possible to determine the activity
in the ‘out-of-hours’ period other than at weekends. The
response rate among patients was disappointing, and it
is likely that there was a self-selection bias, although the
impact of this on the data is unclear.
The frequency and characteristics of emergency
supply requests were broadly similar to those found in
the 1998 study by O’Neill et al.3 Comparisons with
Health and Social Care Information Centre (HSCIC)
data17 on prescriptions dispensed in the community
suggest that cardiovascular, endocrine and gastrointes-
tinal medicines were requested in proportions that
broadly reﬂect their prescribed usages. However, medi-
cines for respiratory conditions were over-represented
among the requests, with 13% of requests being from
this category, when they only account for 6% of pre-
scribed items nationwide. In line with previous general
studies of medicine dispensing,4–7 pharmacists and prac-
tice staff struggled with the issue of what constituted
‘immediate need’. This study extended the ﬁeld by
examining the patient and GP perspective.
The interactions with patients that arise from emergency
supplies provide opportunities for CPs to engage with
patients around medicines use and adherence. Changes to
current practice were supported by CPs and GPs in this
study. One approach would be to formalise the current
service, remunerating CPs for the extra work involved. It
was felt that such a service would have clear beneﬁts in
reducing pressure on other services, providing better struc-
ture and support for patients and supporting patients in
adhering to their treatment to maximise the beneﬁt from
this. It should also include a feedback loop between the
pharmacy and practice through which repeated requests,
and to ensure any inappropriate requests (eg, bypassing a
practice medicines review by going to the pharmacy), can
be discussed and joint action taken. Technological
advances regarding electronic prescribing and access to
electronic patient records might also assist in the effective
handling of emergency supply requests, although the
impact of these advances is currently unclear.
A uniform service may also reduce patient frustration
arising from the current pharmacist-level decision-
making regarding whether or not an emergency supply
or loan is made. However, this may be seen as reducing
professional autonomy, which may impact on clinical out-
comes for individual patients. A similar service is already
commissioned in Scotland,20 and the speciﬁcation for an
English scheme has been developed.14 The RPS report
Now or Never,11 regarding new models of care for phar-
macy, has emphasised the opportunity for community
pharmacy to become a ﬁrst point of call for patients, thus
reducing pressure on other NHS services. Investment in
pharmacy services would be justiﬁed by the ensuing efﬁ-
ciency savings. Jointly, general practice and community
pharmacy would beneﬁt from discussing ways to improve
the repeat prescribing process. This may involve formal-
isation of the emergency supply or loan process in the
short term, coupled with medium-term exploration of
pharmacy-based repeat prescription management. These
practice changes need to be underpinned by open com-
munication and good relationships between the profes-
sions; this study shows that emergency supply is a shared
challenge to stimulate positive joint working.
Non-adherence can reduce the beneﬁts of medicines,21
leading to therapeutic failure with consequential add-
itional economic costs arising from further treatment
needs. It was notable that patients did not necessarily per-
ceive missing doses of their medicines to be a problem,
and this should be addressed as appropriate during coun-
selling. Furthermore, the opportunity for patients to cir-
cumvent the repeat prescribing process by going straight
to the pharmacy and requesting a loan may result in
dilemmas and discomfort for GPs and pharmacists alike.
It has recently been announced that all community phar-
macies in England will audit emergency supply of medi-
cines in 2014/2015 as part of their NHS funding
settlement.22 Further complementary work to examine
the patient pathway up to, and following, an emergency
supply would help GPs and pharmacists to implement
systems to ensure continuous treatment.
CONCLUSION
CPs regularly provide emergency supplies to patients
who have run out of their repeat medication, including
during practice opening hours. This may aid adherence,
but there is currently no feedback loop to general prac-
tice. Patient care and interprofessional communication
may be better served by the introduction of a formally
structured and funded NHS emergency supply service
from community pharmacies, with ongoing optimisation
of repeat prescribing. This could form a more coordi-
nated component of better integrated health and social
care pathways, thus ensuring that patients beneﬁt from
being able to maintain adherence to their prescribed
medicines regime.
Author affiliations
1School of Pharmacy and Biomolecular Sciences, Liverpool John Moores
University, Liverpool, UK
Morecroft CW, et al. BMJ Open 2015;5:e006934. doi:10.1136/bmjopen-2014-006934 9
Open Access
2Division of Health Research, Lancaster University, Lancaster, UK
3Green Line Consulting Ltd, Manchester, UK
4School of Pharmacy and Biomedical Sciences, University of Central
Lancashire, Preston, UK
5Manchester Pharmacy School, University of Manchester, Manchester, UK
6NIHR NW Coast Clinical Research Network, Liverpool, UK
7Independent Pharmacist Researcher, Manchester, UK
Acknowledgements The research team would like to thank the pharmacist
interviewers for their hard work on this project, and the pharmacists who
agreed to be interviewed. This study was developed by the North West (NW)
Primary Care Pharmacy Research Group workgroup and was facilitated by the
NW Primary Care Research Network (PCRN); this steering group includes
academic members from the Region’s three Schools of Pharmacy (Liverpool
John Moores University, the University of Manchester, and the University of
Central Lancashire) and practising community pharmacists. This workgroup is
actively involved in building research capacity among community pharmacists
from both independent and multiple pharmacy companies in the NW region
of England.
Collaborators Clive Moss-Barclay initiated the collaborative project and
advised on pharmacy training and policy.
Contributors CWM designed data collection tools, monitored data collection
for the whole trial, supervised the research assistant and ran training days,
wrote the analysis plan, and drafted and revised the manuscript. He is the
guarantor. AJM implemented the study, supervised the research assistant and
ran training days, analysed the data, and drafted and revised the manuscript.
ECS undertook fieldwork, supervised pharmacists to collect data, analysed the
data and drafted and revised the manuscript. DMA revised data collection
tools, monitored data collection and analysis, and revised the draft
manuscript. SEW revised data collection tools, monitored data collection and
analysis, and revised the draft manuscript. NM created and piloted the audit
tool, developed the audit analysis plan, monitored data collection and
analysis, and revised the draft manuscript. GBP created and piloted the audit
tool, developed the audit analysis plan, monitored data collection and
analysis, and revised the draft manuscript. NJG initiated the collaborative
project, revised data collection tools, monitored data collection and analysis
for the whole trial, and drafted and revised the manuscript. All authors
designed the study.
Funding This study was funded by a research grant from Pharmacy Research
UK http://www.pharmacyresearchuk.org/
Competing interests CWM, AJM and ECS have support from Pharmacy
Research UK for the submitted work; and NJG has support from Liverpool
John Moores University for the submitted work. AJM has received locum fees
from community pharmacy contractors; NJG has received research funding
from Pharmacy Research UK and Community Pharmacy Greater Manchester;
and NM and GBP are employees of Boots Pharmacy, all of which
organisations might have an interest in the submitted work—in the previous
3 years. CWM, AJM, NJG, DMA, NM and GBP are all pharmacists registered
with the General Pharmaceutical Council.
Patient consent Obtained.
Ethics approval Ethical approval was obtained in October 2012 from the
West Midlands Black Country National Research Ethics Service Committee
(12/WM/0364) and Liverpool John Moores University (LJMU) Ethics
Committee (12/PBS/005).
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
Open Access This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license,
which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/4.0/
REFERENCES
1. Statutory Instruments. The Human Medicines Regulations 2012. No.
1916. London: The Stationery Office, 2012.
2. Royal Pharmaceutical Society. Medicines, ethics and practice the
professional guide for pharmacists. Number 37. London, 2013.
3. O’Neill R, Rowley E, Smith F. The emergency supply of
prescription-only medicines: a survey of requests to community
pharmacists and their views on the procedures. Int J Pharm Pract
2002;10:77–83.
4. Hibbert D, Rees JA, Smith I. Ethical awareness of community
pharmacists. Int J Pharm Pract 2000;8:82–7.
5. Cooper RJ, Bissell P, Wingfield J. Dilemmas in dispensing, problems
in practice? Ethical issues and law in UK community pharmacy.
Clin Ethics 2007;2:103–8.
6. Chaar BB, Brien J, Krass I. Professional ethics in pharmacy practice:
developing a psychometric measure of moral reasoning. Pharm
World Sci 2009;31:439–49.
7. Deans Z. Ethics in pharmacy practice, for pharmacy practice
research trust. 2010.
8. Shepherd MD. Examination of why some community pharmacists do
not provide 72-hour emergency prescription drugs to Medicaid
patients when prior authorization is not available. J Manag Care
Pharm 2013;19:527–33.
9. Urgent Care 24 (UC24)/NHS England (Merseyside). GP Out of
Hours services data: Repeat medication requests 1st September–1st
September 2013. Liverpool: UC24, 2013.
10. Department of Health. The NHS belongs to the people: a call to
action. London: Department of Health, 2013.
11. Smith J, Picton C, Dayan M. Now or Never: shaping pharmacy for the
future. The Report of the Commission on future models of care delivered
through pharmacy. Royal Pharmaceutical Society, London, 2013.
12. Department of Health, Prime Minister’s Office. Prime Minister
announces £500 million to relieve pressures on A&E. https://www.
gov.uk/government/news/prime-minister-announces-500-million-to-
relieve-pressures-on-ae (accessed 1 Oct 2014).
13. Pharmaceutical Services Negotiating Committee (PSNC). New
Directions allow Enhanced services for emergency supply. http://
psnc.org.uk/our-news/new-directions-allow-enhanced-services-for-
emergency-supply/ (accessed 1 Oct 2014).
14. Pharmaceutical Services Negotiating Committee (PSNC). NHS
Community Pharmacy Contractual Framework: Enhanced Service—
NHS Emergency Supply Service (at the request of the patient) Draft
service specification [Internet]. 2009. http://psnc.org.uk/wp-content/
uploads/2013/07/NHS_emergency_supply_framework.doc
(accessed 1 Oct 2014).
15. Chew-Graham CA, May CR, Perry MS. Qualitative research and the
problem of judgement: lessons from interviewing fellow
professionals. Fam Pract 2002;19:285–9.
16. Hsieh H-F, Shannon SE. Three approaches to content analysis.
Qual Health Res 2005;15:1277–88.
17. Prescribing and Primary Care Services: Health and Social Care
Information Centre. Prescriptions Dispensed in the Community:
England 2002–12. London, 2013.
18. Department of Health. The National Health Service Act 2006. The
Pharmaceutical Services (Advanced and Enhanced Services)
(England) (Amendment) (No. 2) Directions 2013. London:
Department of Health, 2013.
19. Morecroft CW, Gray NJ, Mackridge AJ, et al. Involving community
pharmacists in pharmacy practice research: experiences of peer
interviewing. Int J Clin Pharm 2015;37:31–5.
20. NHS Scotland. National patient group direction: urgent provision of
repeat medicines, appliances and ACBS products. Operational
Procedure for Pharmacists. 2013.
21. National Institute for Health and Clinical Excellence (NICE). Clinical
guideline 76, Medicines adherence: Involving patients in decisions
about prescribed medicines and supporting adherence. London, 2009.
22. Pharmaceutical Services Negotiating Committee (PSNC). PSNC
Announcement: Community Pharmacy Funding Settlement for 2014/
15. PSNC website news, 22nd September 2014. http://psnc.org.uk/
our-news/psnc-announcement-community-pharmacy-funding-
settlement-201415/ (accessed 1 Oct 2014).
10 Morecroft CW, et al. BMJ Open 2015;5:e006934. doi:10.1136/bmjopen-2014-006934
Open Access
